Opinion|Videos|March 28, 2025

Balancing Effective AD Symptom Control with Long-Term Safety in New Therapies

Lisa Swanson, MD, FAAD, discusses how to balance the need for effective control of Alzheimer's disease symptoms with concerns about long-term safety, particularly when introducing new therapies.

Episodes in this series

This news content has been independently developed and is not endorsed by the American Academy of Dermatology.

Video content above is prompted by the following:

  • How do you balance the need for effective control of AD symptoms with concerns about long-term safety, particularly when introducing new therapies?

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME